Meet The Team - Sinead Watson - Head of Clinical & Regulatory

Meet The Team - Sinead Watson - Head of Clinical & Regulatory

My name is Sinead Watson, and I joined Neurovalens in September 2022. My role at Neurovalens is Head of Clinical & Regulatory that involves leading the clinical team in the planning, execution and delivery of several clinical trials and regulatory submissions.
February 07, 2024 — Craig McConnell
Meet The Team - Rachel Robinson - Lead Clinical Researcher

Meet The Team - Rachel Robinson - Lead Clinical Researcher

My name is Rachel Robinson and I joined Neurovalens in September 2022 as a Lead Clinical Researcher. From a young age I was always fascinated about the function and development of the human body and this is the main reason I chose to focus my studies within the fields of anatomy and physiology.
January 04, 2024 — Craig McConnell
Meet The Team - Steven George - Software QA Manager

Meet The Team - Steven George - Software QA Manager

I'm Steven George, but most people know me as Stevie. I've been at Neurovalens almost 6 years, it feels like no time since I joined yet so much has changed and so much has been achieved.
November 22, 2023 — Craig McConnell
The Irish News | Latest cash injection sees medical tech firm Neurovalens target US growth

The Irish News | Latest cash injection sees medical tech firm Neurovalens target US growth

A BELFAST technology firm developing a number of specialised medical devices has received its second major cash injection in a month.
Neurovalens has been boosted by £750,000 from the Growth Finance Fund to support the launch of a new sleep product in the USA later this year.

January 21, 2022 — Chris Miskelly
Belfast Newsletter | Health tech company creates 22 new jobs

Belfast Newsletter | Health tech company creates 22 new jobs

Belfast-based health tech company Neurovalens is set to create 22 new jobs with the development of a ground-breaking medical device.

Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings.

January 21, 2022 — Chris Miskelly